Literature DB >> 18167187

Osteopontin gene polymorphism in association with systemic lupus erythematosus in Chinese patients.

An-ping Xu1, Jie Bai, Jun Lü, Yan-yi Liang, Jin-gao Li, De-yuan Lai, Xia Wan, Hu-hui Huang.   

Abstract

BACKGROUND: Osteopontin (OPN) is one kind of cytokine which can play a number of roles in promoting activation of T lymphocyte, regulating balance between Th1 and Th2, participating in cell-induced immunologic response and stimulating B lymphocyte to express multi-clone antibodies. Some researches have showed that OPN may be involved in the pathogenesis of systemic lupus erythematosus (SLE). The aim of this study was to investigate possible association of a single nucleotide polymorphism (SNP) at position 9250 in exon 7 of the OPN gene (OPN gene 9250) with SLE in Chinese patients.
METHODS: Totally 158 patients (18 males and 140 females) fulfilled the revised criteria for SLE by the American College of Rheumatology in 1982 and 180 healthy volunteer controls (34 males and 146 females), all from the south of China, consented to participate in the study. OPN gene 9250 polymorphism was detected by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP).
RESULTS: The frequency of TT genotype of the OPN gene 9250 was significantly lower (52.5% vs 70%, P < 0.05) and the frequency of TC genotype of the OPN gene 9250 was significantly higher (43.7% vs 29.4%, P < 0.05) in SLE patients than in controls. There were significant differences in OPN gene 9250 allele and phenotype frequencies between the SLE patients and controls (P < 0.05). When the SLE patients and controls were separated into men and women, significant differences of frequencies were noted in TT genotype, TC genotype and allele of the OPN gene 9250 in women (P < 0.05) but not in men (P > 0.05).
CONCLUSIONS: OPN gene 9250 polymorphism appears to be associated with susceptibility to SLE in Chinese Han ethnic population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18167187

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  13 in total

1.  Male-only systemic lupus.

Authors:  Rachna Aggarwal; Bahram Namjou; Shibo Li; Anil D'Souza; Betty P Tsao; Benjamin F Bruner; Judith A James; R Hal Scofield
Journal:  J Rheumatol       Date:  2010-05-15       Impact factor: 4.666

2.  Application of Various Statistical Models to Explore Gene-Gene Interactions in Folate, Xenobiotic, Toll-Like Receptor and STAT4 Pathways that Modulate Susceptibility to Systemic Lupus Erythematosus.

Authors:  Yedluri Rupasree; Shaik Mohammad Naushad; Ravi Varshaa; Govindaraj Swathika Mahalakshmi; Konda Kumaraswami; Liza Rajasekhar; Vijay Kumar Kutala
Journal:  Mol Diagn Ther       Date:  2016-02       Impact factor: 4.074

Review 3.  The role of osteopontin in kidney diseases.

Authors:  Beata Kaleta
Journal:  Inflamm Res       Date:  2018-11-19       Impact factor: 4.575

4.  Osteopontin is associated with increased arterial stiffness in rheumatoid arthritis.

Authors:  Laura Bazzichi; Lorenzo Ghiadoni; Alessandra Rossi; Melania Bernardini; Mario Lanza; Francesca De Feo; Camillo Giacomelli; Ilaria Mencaroni; Katia Raimo; Marco Rossi; Anna Maria Mazzone; Stefano Taddei; Stefano Bombardieri
Journal:  Mol Med       Date:  2009-06-18       Impact factor: 6.354

5.  Association of the osteopontin rs1126616 polymorphism and a higher serum osteopontin level with lupus nephritis.

Authors:  Saeedeh Salimi; Mehrangiz Noora; Sima Nabizadeh; Mahnaz Rezaei; Hossain Shahraki; Mohammadoo-Khorassani Milad; Anoosh Naghavi; Farzaneh Farajian-Mashhadi; Zahra Zakeri; Mahnaz Sandoughi
Journal:  Biomed Rep       Date:  2016-02-02

6.  Association of IRF5 polymorphisms with activation of the interferon alpha pathway.

Authors:  Ornella J Rullo; Jennifer M P Woo; Hui Wu; Alice D C Hoftman; Paul Maranian; Brittany A Brahn; Deborah McCurdy; Rita M Cantor; Betty P Tsao
Journal:  Ann Rheum Dis       Date:  2009-10-23       Impact factor: 19.103

7.  The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease.

Authors:  Jürgen Glas; Julia Seiderer; Corinna Bayrle; Martin Wetzke; Christoph Fries; Cornelia Tillack; Torsten Olszak; Florian Beigel; Christian Steib; Matthias Friedrich; Julia Diegelmann; Darina Czamara; Stephan Brand
Journal:  PLoS One       Date:  2011-12-29       Impact factor: 3.240

8.  Genetics of osteopontin in patients with chronic kidney disease: The German Chronic Kidney Disease study.

Authors:  Yurong Cheng; Yong Li; Nora Scherer; Franziska Grundner-Culemann; Terho Lehtimäki; Binisha H Mishra; Olli T Raitakari; Matthias Nauck; Kai-Uwe Eckardt; Peggy Sekula; Ulla T Schultheiss
Journal:  PLoS Genet       Date:  2022-04-06       Impact factor: 5.917

Review 9.  Role of osteopontin in systemic lupus erythematosus.

Authors:  Beata Kaleta
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-06-11       Impact factor: 4.291

10.  Polymorphisms in the Osteopontin Are Associated with Susceptibility to Ankylosing Spondylitis in a Han Chinese Population.

Authors:  Juyi Li; Yi Cai; Zhongjing Wang; Aiping Deng; Guoliang Yang
Journal:  Biomed Res Int       Date:  2018-01-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.